Press releases
- Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
- Elanco to Participate in Stifel 2024 Jaws and Paws Conference
- Elanco Animal Health Reports First Quarter 2024 Results
- Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
- Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
- Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
- Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.11 |
---|---|
High | 16.34 |
Low | 16.07 |
Bid | 16.25 |
Offer | 16.34 |
Previous close | 16.28 |
Average volume | 31.30 |
---|---|
Shares outstanding | 494.18m |
Free float | 490.93m |
P/E (TTM) | -- |
Market cap | 8.74bn USD |
EPS (TTM) | -2.64 USD |
Data delayed at least 15 minutes, as of May 31 2024 18:32 BST.
More ▼